Our overall HIPC proposal, entitled ?Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity?, will leverage cutting-edge Projects and Cores to identify age-specific OMIC signatures that correlate with vaccine immunogenicity in newborns and infants recruited at Clinical Core (CC)-Sites in West Africa (The Gambia) and Australasia (Papua New Guinea). Given the scientific scope, complexity, and geographic range of the proposed work, a well-designed Administrative Core will be crucial to optimize the quality and impact of the proposed studies and to ensure provision of project deliverables. The goal of our Administrative Core is to institute streamlined processes facilitating seamless, synergistic, and productive interactions among investigators from each HIPC Project and Core. We will achieve this goal by pursuing the following Specific Aims (SAs): SA1. Provide infrastructure for administrative leadership aimed at building an interactive and collaborative working team resulting in maximal project synergy SA2. Facilitate and promote communication and interactions amongst the Project and Core Leads by conducting regular teleconferences/face-to-face meetings, annual meetings, as well as seminars/symposia focused on the HIPC. SA3. Manage and optimize communication within the HIPC and between the HIPC and HIPC Steering Committee. SA4. Resolve potential conflicts that might arise within and outside of our HIPC by implementing recommendations of the Conflicts Resolution Group (CRG). SA5. Provide fiscal, regulatory and scientific oversight, review and consolidate yearly progress reports sent to the NIH. SA6. Protect intellectual property rights of our investigators and execute material transfer agreements. SA7. Implement the data management/sharing plan among investigators within and outside of our HIPC team. Overall, the HIPC Administrative Core will ensure appropriate stewardship of NIH funds, adherence to HIPC project timelines, and will optimize and amplify the scientific impact of the proposed studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI118608-05
Application #
10063818
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2016-12-27
Project End
2021-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
5
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Boston Children's Hospital
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Scheid, Annette; Borriello, Francesco; Pietrasanta, Carlo et al. (2018) Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn. Front Immunol 9:29
Lux, Markus; Brinkman, Ryan Remy; Chauve, Cedric et al. (2018) flowLearn: fast and precise identification and quality checking of cell populations in flow cytometry. Bioinformatics 34:2245-2253
Borriello, Francesco; van Haren, Simon D; Levy, Ofer (2018) First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines. mSphere 3: